Diterpenoids from Euphorbia dulcis with Potassium Ion Channel Inhibitory Activity with Selective G Protein-Activated Inwardly Rectifying Ion Channel (GIRK) Blocking Effect

Nine new (1-9) and two known (10, 11) jatrophane diterpenoids were isolated from the methanol extract of Euphorbia dulcis. The structure elucidation of the compounds was performed by means of extensive spectroscopic analysis, including HRESIMS, 1D (H-1, JMOD), and 2D (HSQC, HMBC, H-1-H-1-COSY, NOESY...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Kúsz Norbert
Orvos Péter
Nagyné Bereczki Laura
Fertey Pierre
Bombicz Petra
Csorba Attila
Jakab Gusztáv
Hohmann Judit
Rédei Dóra
Dokumentumtípus: Cikk
Megjelent: 2018
Sorozat:JOURNAL OF NATURAL PRODUCTS 81 No. 11
doi:10.1021/acs.jnatprod.8b00500

mtmt:30320593
Online Access:http://publicatio.bibl.u-szeged.hu/14454
Leíró adatok
Tartalmi kivonat:Nine new (1-9) and two known (10, 11) jatrophane diterpenoids were isolated from the methanol extract of Euphorbia dulcis. The structure elucidation of the compounds was performed by means of extensive spectroscopic analysis, including HRESIMS, 1D (H-1, JMOD), and 2D (HSQC, HMBC, H-1-H-1-COSY, NOESY) NMR experiments. The absolute configuration of compound 1 was determined by single-crystal X-ray diffraction. The electro physiological effects of compounds 1-11 and the five diterpenoids (12-16) previously isolated from Euphorbia taurinensis were investigated on stable transfected HEK-GIRK1/4 (Kir3.1/3.4) and HEK-hERG (Kv11.1) cell lines using automated patch-clamp equipment. The majority of the diterpenoids showed significant blocking activity on GIRK channels (60.8-88.7% at 10 mu M), while compounds 1, 2, 9-11, 13, and 14 exerted notable inhibitory effects even at 1 mu M concentration. None of the jatrophane diterpenoids interfered with the function of hERG proteins; however, compound 14 remarkably hampered K+ flow through hERG channels. These selective activities suggest that jatrophane diterpenoids may represent a group of potential lead compounds for the development of novel therapeutic agents against atrial fibrillation.
Terjedelem/Fizikai jellemzők:2483-2492
ISSN:0163-3864